Tamer Hellou: Chromosome 1q Gain Signals High Long-Term Risk in AL Amyloidosis
Tamer Hellou, Advanced Hematology Clinical Fellowship at Mayo Clinic Rochester, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in American Journal of 0f Hematology, adding:
”Excited to share our newly published work in the American Journal of Hematology:
‘Chromosome 1q Gain Defines a Plasma Cell–Dominant Adverse-Risk Subtype in AL Amyloidosis With Inferior Long-Term Survival.’
In this study of 517 patients with newly diagnosed AL amyloidosis, +1q identified a distinct plasma cell–dominant phenotype, characterized by greater clonal burden and inferior long-term survival, while other high-risk cytogenetic lesions did not show the same adverse prognostic impact.
Importantly, despite good early hematologic and organ responses, patients with +1q remained at risk for poorer long-term outcomes, with its adverse impact becoming particularly evident beyond two years, highlighting the importance of long-term vigilance even in patients who respond well initially.
Grateful to Eli Muchtar and all my colleagues and collaborators at Mayo Clinic for their guidance and contributions to this work.”
Title: Chromosome 1q Gain Defines a Plasma Cell–Dominant Adverse-Risk Subtype in AL Amyloidosis With Inferior Long-Term Survival
Authors: Tamer Hellou, Estefania Gauto Mariotti, Ahmed Alnughmush, Linda B. Baughn, Prashant Kapoor, Saurabh Zanwar, Shinichiro Suzuki, Maximilian J. Steinhardt, Daniel G. Packard, Taxiarchis V. Kourelis, Francis K. Buadi, David Dingli, Suzanne R. Hayman, Nelson Leung, Yi Lisa Hwa, Amie Fonder, Miriam Hobbs, Rahma Warsame, Joselle Cook, Moritz Binder, Nadine Abdallah, Yi Lin, Ronald S. Go, Robert A. Kyle, S. Vincent Rajkumar, Wilson I. Gonsalves, Shaji K. Kumar, Morie A. Gertz, Angela Dispenzieri, Eli Muchtar
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 13, 2026, 12:29Mariam Al Mansoori: 5th International Hemophilia Conference
-
Oct 13, 2026, 12:13Hemophilia Outreach of Wisconsin Attends VWD Connect Conference
-
Oct 13, 2026, 11:41Abhishek Kumar: How Three Hemophilia Patients Helped Secure Life-Saving Treatment in Bihar
-
Oct 13, 2026, 11:24Brandon Daniel D’Costa: Building Stronger Stakeholder Relationships Through Empathy and Open Communication
-
Oct 13, 2026, 11:08Renel Tique: 5th International Conference on Hemophilia and Rare Bleeding Disorders
-
Oct 13, 2026, 02:01Nour Al-Mozain: Is It Really Anti-D? – Unraveling Auto-Anti-LW in the Transfusion Laboratory
-
Oct 13, 2026, 01:51Berenice Villegas: The Role of Morphologic Evaluation in Body Fluid Differential Analysis
-
Oct 13, 2026, 01:44Debadrita Ray: Evaluating vWF and VITRO Score for Detecting CSPH in cACLD Patients
-
Oct 13, 2026, 01:34Nagesh Ramesh: Donating Blood for International Plasma Awareness Week